华西医学2024,Vol.39Issue(9) :1427-1434.DOI:10.7507/1002-0179.202403043

中国白血病发病、患病及死亡趋势分析及预测研究

Analysis and prediction of the incidence,morbidity and death of leukemia in China

谭茜蔚 王仕鸿 王爽 曹汝岱 丁元林 张炳松 于海兵
华西医学2024,Vol.39Issue(9) :1427-1434.DOI:10.7507/1002-0179.202403043

中国白血病发病、患病及死亡趋势分析及预测研究

Analysis and prediction of the incidence,morbidity and death of leukemia in China

谭茜蔚 1王仕鸿 1王爽 1曹汝岱 1丁元林 1张炳松 1于海兵2
扫码查看

作者信息

  • 1. 广东医科大学公共卫生学院(广东东莞 523808)
  • 2. 广东医科大学公共卫生学院(广东东莞 523808);广东医科大学附属东莞第一医院(广东东莞 523808);省部共建中亚高发病成因与防治国家重点实验室(广东东莞 523808);东莞市慢性病防治重点实验室(广东东莞 523808)
  • 折叠

摘要

目的 分析1990年-2019年中国白血病流行情况,预测2020年-2040年中国白血病发病、患病及死亡情况,为中国白血病相关防治策略的制订提供参考.方法 基于2019年全球疾病负担数据库,收集1990年-2019年中国白血病的发病、患病和死亡数据,采用变化率(%)和年估计变化百分比(estimated annual percentage change,EAPC)描述疾病的流行趋势.运用自回归移动平均模型预测2020年-2040年中国白血病的流行情况.结果 2019年中国白血病年龄标准化发病率、年龄标准化患病率和年龄标准化死亡率较1990年分别下降17.62%、10.97%和41.56%,年均分别下降1.06%、0.89%和2.05%(P<0.05);1990年-2019年中国女性年龄标准化发病率、年龄标准化患病率和年龄标准化死亡率的下降速度(EAPC分别为1.56%、1.38%、2.62%)均高于男性(EAPC分别为0.61%、0.43%、1.59%);2019年5岁以下年龄组发病率和患病率最高,80岁以上年龄组死亡率最高.ARIMA模型预测结果表明,2020年-2040年中国白血病年龄标准化发病率、年龄标准化患病率呈上升趋势,年龄标准化死亡率呈下降趋势.预计到2040年白血病的年龄标准化发病率、年龄标准化患病率和年龄标准化死亡率分别为14.06/10万、108.23/10万、2.83/10万.结论 1990年-2019年,中国白血病的年龄标准化发病率、年龄标准化患病率及年龄标准化死亡率呈逐年下降,但仍处于较高水平.预测结果显示2020年-2040年中国白血病年龄标准化发病率和年龄标准化患病率仍然呈上升趋势,未来仍需继续加强白血病的监测及防控工作.

Abstract

Objective To analyze the prevalence of leukemia in China from 1990 to 2019,predict the incidence,morbidity and mortality of leukemia in China from 2020 to 2040,and provides reference for the formulation of leukemia-related prevention and treatment strategies in China.Methods Based on the 2019 Global Burden of Disease database,the incidence,morbidity and mortality data of leukemia in China from 1990 to 2019 were collected,and the rate of change and annual estimated percentage of change(EAPC)were used to describe the epidemic trend of the disease.The Autoregressive Moving Average(ARIMA)model was used to predict the prevalence of leukemia in China from 2020 to 2040.Results In 2019,the age-standardized incidence,age-standardized prevalence and age-standardized mortality rate of leukemia in China decreased by 17.62%,10.97%,and 41.56%,respectively,compared with 1990,and an average annual decrease of 1.06%,0.89%,and 2.05%,respectively(P<0.05).From 1990 to 2019,the reduction age-standardized incidence rate,age-standardized prevalence rate and age-standardized mortality rate in Chinese women(EAPC was 1.56%,1.38%,and 2.62%,respectively)was higher than that of men(EAPC was 0.61%,0.43%,and 1.59%,respectively).In 2019,the incidence and prevalence were highest in the age group under 5 years of age,and the mortality rate was the highest in the age group over 80 years old.The prediction results of ARIMA model showed that the age-standardized incidence rate and prevalence of leukemia in China showed an increasing trend from 2020 to 2040,while the age-standardized mortality rate showed a decreasing trend.It is estimated that by 2040,the age-standardized incidence rate,age-standardized prevalence rate,and age-standardized mortality rate of leukemia will be 14.06/100 000,108.23/100 000,and 2.83/100 000.Conclusions From 1990 to 2019,the age-standardized incidence rate,age-standardized prevalence rate and age-standardized mortality rate of leukemia in China decreased year by year,but they were still at a high level.The prediction results show that the age-standardized incidence rate and age-standardized prevalence rate of leukemia in China will continue to increase from 2020 to 2040,and it is necessary to continue to strengthen the surveillance,prevention and control of leukemia in the future.

关键词

白血病/全球疾病负担报告/变化趋势/预测分析

Key words

Leukemia/global burden of disease/changing trend/forecasting analysis

引用本文复制引用

出版年

2024
华西医学
四川大学华西医院

华西医学

CSTPCD
影响因子:0.744
ISSN:1002-0179
段落导航相关论文